| A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (NCT05311254) | Fundación para la Investigación Biosanitaria del Principado de Asturias | 2022-03-14 |
| Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial. (NCT04698057) | Poitiers University Hospital | 2022-03-01 |
| Impact of Computerized Decision Support for ANTIBIOtic Prescription in Cancer Patients With Febrile NEutropenia in the Emergency Department on Treatment Failure. (NCT05206006) | Assistance Publique - Hôpitaux de Paris | 2022-02-14 |
| mNGS Versus Blood Culture in FN (NCT05149547) | Peking University People's Hospital | 2021-10-15 |
| Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology (NCT04758442) | Ciusss de L'Est de l'Île de Montréal | 2021-02-01 |
| An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (NCT04662892) | Coherus Oncology, Inc. | 2020-08-01 |
| Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia (NCT04910698) | Poitiers University Hospital | 2020-01-01 |
| Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer (NCT03618810) | Zhejiang Cancer Hospital | 2019-01-20 |
| G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients (NCT03793205) | Lei Li | 2019-01-03 |
| Long-acting G-CSF for Febrile Neutropenia (NCT03740464) | Lei Li | 2018-11-10 |
| Ampholipad Real-World Data in Taiwan (NCT03641131) | Taiwan Liposome Company | 2018-09-09 |
| Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents (NCT03619252) | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | 2018-07-01 |
| iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients (NCT03364257) | Pathoquest | 2018-05-18 |
| Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematology (NCT03342365) | Centre Hospitalier Universitaire de Nīmes | 2018-04-13 |
| PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia (NCT03429387) | Peter MacCallum Cancer Centre, Australia | 2018-01-08 |
| Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer (NCT03104595) | Enzychem Lifesciences Corporation | 2017-10-30 |
| Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia (NCT03449693) | Universidad Nacional Autonoma de Mexico | 2017-10-19 |
| Shared Health Information System for Febrile Neutropenia (NCT03087227) | Marie-Helene METZGER | 2017-02-22 |
| Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant (NCT03078010) | Memorial Sloan Kettering Cancer Center | 2017-02-10 |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) (NCT02728596) | SWOG Cancer Research Network | 2016-10-07 |
| Profiling Neutrophil Counts in Patients on Chemotherapy (NCT02806557) | University of Leeds | 2016-09-01 |
| Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia (NCT02856204) | Stanford University | 2016-08-01 |
| Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer (NCT02732327) | Forest Laboratories | 2016-05-17 |
| Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) (NCT02685111) | Asan Medical Center | 2016-02-01 |
| The Oral Cavity as a Source of Febrile Neutropenia (NCT02702583) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-12-01 |
| Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients (NCT03968328) | M.D. Anderson Cancer Center | 2015-06-19 |
| Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia (NCT02463747) | Tel-Aviv Sourasky Medical Center | 2015-06-01 |
| Cohort of Peripheral T Cell Lymphoma (NCT02364466) | Korea Cancer Center Hospital | 2015-01-01 |
| Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO (NCT02149329) | Amsterdam UMC, location VUmc | 2014-12-01 |
| Early Antibiotic Discontinuation in FUO (NCT02906254) | University Hospital, Brest | 2014-02-01 |
| Study of Danggui Buxue Decoction in Preventing Neutropenia (NCT02005783) | Shanghai Jiao Tong University School of Medicine | 2013-10-01 |
| A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy (NCT01560195) | Jiangsu HengRui Medicine Co., Ltd. | 2012-04-01 |
| Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia (NCT01581333) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2012-04-01 |
| A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy (NCT01611051) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia (NCT01450241) | Rabin Medical Center | 2012-01-01 |
| Registry of Febrile Neutropenia and Invasive Fungal Infections (NCT01684189) | Chang Gung Memorial Hospital | 2011-11-01 |
| Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases (NCT01344681) | Yonsei University | 2011-06-01 |
| Daptomycin Versus Placebo in Patients With Neutropenia and Fever (NCT01216241) | University of Rochester | 2011-04-01 |
| A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy (NCT02119715) | Jiangsu HengRui Medicine Co., Ltd. | 2011-02-01 |
| Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients (NCT01401010) | Gary E. Stein, Pharm.D. | 2010-08-01 |
| Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients (NCT02544685) | S&D Pharma SK s.r.o. | 2010-07-01 |
| Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients (NCT01114165) | University Hospital Muenster | 2010-05-01 |
| Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor (NCT01459653) | Sandoz | 2010-03-01 |
| Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia (NCT00928291) | Federal University of Minas Gerais | 2010-01-01 |
| Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options (NCT00945555) | Pfizer | 2009-06-01 |
| Various G-CSF Regimens to Prevent Infection During Chemotherapy (NCT00536081) | Academisch Ziekenhuis Maastricht | 2008-01-01 |
| Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia (NCT00723073) | Brigham and Women's Hospital | 2008-01-01 |
| Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia (NCT00503854) | M.D. Anderson Cancer Center | 2007-05-31 |
| Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics (NCT00421187) | Gilead Sciences | 2007-03-01 |
| Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases (NCT00137787) | Center for Supporting Hematology-Oncology Trials | 2005-04-01 |
| Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients (NCT00454272) | Sanofi | 2005-01-01 |
| Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation (NCT00462878) | PETHEMA Foundation | 2002-11-01 |
| Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection (NCT00035425) | Pfizer | 2001-11-01 |